Announcement on the implementation of the "Improving Quality and Efficiency, Returning Benefits" action by autobio diagnostics.
Announcement of Autobio Diagnostics Chairman and Actual Controller's Shareholding and Further Shareholding Plan.
Autobio Diagnostics-Announcement on the Progress of Repurchasing Company Shares through Centralized Bidding Trading
Antu Biotech 2023 Annual Benefit Distribution Implementation Notice
Legal Opinion of Shanghai AllBright Law Firm on Antu Biotech's 2023 Differential Dividend
Antu Biotech's announcement on adjusting the upper limit of the share repurchase price after implementing the 2023 equity distribution
Antu Biotech Investor Relations Activity Record Form (May 20, 2024)
Antu Biotech's announcement on adjusting the allocation amount per share for the 2023 profit distribution plan
Antu Biotech's announcement on its wholly-owned subsidiary obtaining a medical device registration certificate
Antu Biotech's announcement on holding a performance briefing for the first quarter of 2023 and 2024
Announcement of Resolutions of Antu Biotech's 2023 Annual General Meeting of Shareholders
Legal Opinion of Antu Biotech's 2023 Annual General Meeting of Shareholders
Antu Biotech's Announcement on Cancelling the Repurchase of Shares, Reducing Registered Capital, and Notifying Creditors
Antu Biotech's announcement on the use of idle funds raised for cash management and redemption
Antu Biotech's progress announcement on the repurchase of the company's shares through centralized bidding transactions
Antu Biotech Investor Relations Activity Record Form (April 19, 2024)
Antu Biotech's announcement on arbitration matters and progress in foreign investment
Antu Biotech's 2023 Annual General Meeting of Shareholders Meeting Materials
Antu Biotech's announcement on the increase in the company's shares by the chairman and actual controller
Antu Biotech Independent Directors' Special Meeting Work System (established in April 2024)
No Data